share_log

8-K: Current report

8-K: Current report

8-K：重大事件
美股SEC公告 ·  2024/11/14 00:27

Moomoo AI 已提取核心信息

Applied DNA Sciences received a notification from Nasdaq on November 12, 2024, indicating non-compliance with the minimum bid price requirement of $1.00 per share. The company's stock price remained below this threshold for 31 consecutive business days from September 27 to November 11, 2024.The company has been granted until May 12, 2025, to regain compliance by maintaining a closing bid price of at least $1.00 for a minimum of 10 consecutive business days. If unsuccessful, the company may be eligible for an additional 180-day compliance period, provided it meets other Nasdaq Capital Market listing requirements.In response, Applied DNA Sciences plans to implement a reverse stock split within 30 days of the Stockholder Approval Date, as required by their recent securities offering agreement, unless compliance is regained within that period. This action aims to maintain Nasdaq listing and fulfill obligations under the Purchase Agreement from October 31, 2024.
Applied DNA Sciences received a notification from Nasdaq on November 12, 2024, indicating non-compliance with the minimum bid price requirement of $1.00 per share. The company's stock price remained below this threshold for 31 consecutive business days from September 27 to November 11, 2024.The company has been granted until May 12, 2025, to regain compliance by maintaining a closing bid price of at least $1.00 for a minimum of 10 consecutive business days. If unsuccessful, the company may be eligible for an additional 180-day compliance period, provided it meets other Nasdaq Capital Market listing requirements.In response, Applied DNA Sciences plans to implement a reverse stock split within 30 days of the Stockholder Approval Date, as required by their recent securities offering agreement, unless compliance is regained within that period. This action aims to maintain Nasdaq listing and fulfill obligations under the Purchase Agreement from October 31, 2024.
Applied DNA Sciences于2024年11月12日收到了纳斯达克的通知，表示未能满足每股最低买盘价1.00美元的要求。该公司的股票价格在2024年9月27日至11月11日的31个连续交易日内低于该门槛。公司被允许在2025年5月12日之前恢复合规，方法是在至少10个连续交易日内保持至少1.00美元的收盘买盘价。如果不成功，公司可能有资格获得额外180天的合规期，前提是满足其他纳斯达克资本市场上市要求。对此，Applied DNA Sciences计划在股东批准日期后的30天内进行反向股票拆分，这是根据其最近的证券发行协议要求的，除非在该期限内恢复合规。此举旨在维持纳斯达克的上市状态并履行2024年10月31日购买协议下的义务。
Applied DNA Sciences于2024年11月12日收到了纳斯达克的通知，表示未能满足每股最低买盘价1.00美元的要求。该公司的股票价格在2024年9月27日至11月11日的31个连续交易日内低于该门槛。公司被允许在2025年5月12日之前恢复合规，方法是在至少10个连续交易日内保持至少1.00美元的收盘买盘价。如果不成功，公司可能有资格获得额外180天的合规期，前提是满足其他纳斯达克资本市场上市要求。对此，Applied DNA Sciences计划在股东批准日期后的30天内进行反向股票拆分，这是根据其最近的证券发行协议要求的，除非在该期限内恢复合规。此举旨在维持纳斯达克的上市状态并履行2024年10月31日购买协议下的义务。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    Grail
    GRAL
    -- 28.890
    Neuronetics
    STIM
    -- 2.510
    Twist Bioscience
    TWST
    -- 55.100
    23andMe
    ME
    -- 3.620
    燃石医学
    BNR
    -- 7.000
    解锁完整榜单
    热门中概股
    追踪最热门的中概股实时资讯。
    热门讨论
    中美谈话新契机，通胀不再？
    🎙️讨论： 1. 你认为特朗普上台后，对华政策将如何影响中国资产？ 2. 美股市场通胀风险下降，有哪些利好板块？ 展开
    中国将在未来一年采取"适度宽松"的货币政策，这是自2011年以来的首次转向宽松。